1h Free Analyst Time
SummarySpeak directly to the analyst to clarify any post sales queries you may have.
The publisher's latest Pharmaceutical and Healthcare disease pipeline guide Pancreatic Cancer - Pipeline Review, H2 2020, provides an overview of the Pancreatic Cancer (Oncology) pipeline landscape.
Pancreatic cancer is a disease in which malignant (cancer) cells are found in the tissues of the pancreas. This is also called exocrine cancer. Signs and symptoms include upper abdominal pain that may radiate to back, yellowing of skin and the whites of eyes (jaundice), loss of appetite, weight loss, depression and blood clots. Predisposing factors include age, gender, smoking, diabetes and family history. Treatment includes surgery, chemotherapy and radiation therapy.
Report Highlights
The publisher's Pharmaceutical and Healthcare latest pipeline guide Pancreatic Cancer - Pipeline Review, H2 2020, provides comprehensive information on the therapeutics under development for Pancreatic Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Pancreatic Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Pancreatic Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Phase 0, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 3, 22, 207, 220, 2, 14, 386, 63 and 10 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Phase 0, IND/CTA Filed, Preclinical and Discovery stages comprises 27, 14, 3, 1, 67 and 11 molecules, respectively.
Pancreatic Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from the publisher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Note: Certain content/sections in the pipeline guide may be removed or altered based on the availability and relevance of data.
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Pancreatic Cancer (Oncology).
- The pipeline guide reviews pipeline therapeutics for Pancreatic Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Pancreatic Cancer (Oncology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Pancreatic Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Pancreatic Cancer (Oncology)
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Pancreatic Cancer (Oncology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Pancreatic Cancer (Oncology) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Table of Contents
IntroductionPancreatic Cancer - Overview
Pancreatic Cancer - Therapeutics Development
Pancreatic Cancer - Therapeutics Assessment
Pancreatic Cancer - Companies Involved in Therapeutics Development
Pancreatic Cancer - Drug Profiles
Pancreatic Cancer - Dormant Projects
Pancreatic Cancer - Discontinued Products
Pancreatic Cancer - Product Development Milestones
Appendix
List of Tables
- Number of Products under Development for Pancreatic Cancer, H2 2020
- Number of Products under Development by Companies, H2 2020
- Number of Products under Development by Universities/Institutes, H2 2020
- Products under Development by Companies, H2 2020
- Products under Development by Universities/Institutes, H2 2020
- Number of Products by Stage and Target, H2 2020
- Number of Products by Stage and Mechanism of Action, H2 2020
- Number of Products by Stage and Route of Administration, H2 2020
- Number of Products by Stage and Route of Administration, H2 2020 (Contd..1), H2 2020
- Number of Products by Stage and Molecule Type, H2 2020
- Number of Products by Stage and Molecule Type, H2 2020 (Contd..1), H2 2020
- Pancreatic Cancer - Pipeline by 4D Pharma Plc, H2 2020
- Pancreatic Cancer - Pipeline by 4SC AG, H2 2020
- Pancreatic Cancer - Pipeline by A2 Biotherapeutics Inc, H2 2020
- Pancreatic Cancer - Pipeline by AB Pharma Ltd, H2 2020
- Pancreatic Cancer - Pipeline by AB Science SA, H2 2020
- Pancreatic Cancer - Pipeline by AbbVie Inc, H2 2020
- Pancreatic Cancer - Pipeline by AbClon Inc, H2 2020
- Pancreatic Cancer - Pipeline by Ability Pharmaceuticals SL, H2 2020
- Pancreatic Cancer - Pipeline by AC Bioscience SA, H2 2020
- Pancreatic Cancer - Pipeline by Accendatech Co Ltd, H2 2020
- Pancreatic Cancer - Pipeline by Accuronix Therapeutics Inc, H2 2020
- Pancreatic Cancer - Pipeline by ACF Pharmaceuticals LLC, H2 2020
- Pancreatic Cancer - Pipeline by Aclaris Therapeutics Inc, H2 2020
- Pancreatic Cancer - Pipeline by Acrotech Biopharma LLC, H2 2020
- Pancreatic Cancer - Pipeline by Actuate Therapeutics Inc, H2 2020
- Pancreatic Cancer - Pipeline by Acura Nanomedicine Inc, H2 2020
- Pancreatic Cancer - Pipeline by Adamed Sp zoo, H2 2020
- Pancreatic Cancer - Pipeline by ADC Therapeutics SA, H2 2020
- Pancreatic Cancer - Pipeline by Adlai Nortye Biopharma Co Ltd, H2 2020
- Pancreatic Cancer - Pipeline by Aduro BioTech Inc, H2 2020
- Pancreatic Cancer - Pipeline by Diakonos Research Ltd, H2 2020
- Pancreatic Cancer - Pipeline by Loxo Oncology Inc, H2 2020
List of Figures
- Number of Products under Development for Pancreatic Cancer, H2 2020
- Number of Products under Development by Companies, H2 2020
- Number of Products under Development by Universities/Institutes, H2 2020
- Number of Products by Top 10 Targets, H2 2020
- Number of Products by Stage and Top 10 Targets, H2 2020
- Number of Products by Top 10 Mechanism of Actions, H2 2020
- Number of Products by Stage and Top 10 Mechanism of Actions, H2 2020
- Number of Products by Top 10 Routes of Administration, H2 2020
- Number of Products by Stage and Top 10 Routes of Administration, H2 2020
- Number of Products by Top 10 Molecule Types, H2 2020
- Number of Products by Stage and Top 10 Molecule Types, H2 2020
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 4D Pharma Plc
- 4SC AG
- A2 Biotherapeutics Inc
- AB Pharma Ltd
- AB Science SA
- AbbVie Inc
- AbClon Inc
- Ability Pharmaceuticals SL
- AC Bioscience SA
- Accendatech Co Ltd
- Accuronix Therapeutics Inc
- ACF Pharmaceuticals LLC
- Aclaris Therapeutics Inc
- Acrotech Biopharma LLC
- Actuate Therapeutics Inc
- Acura Nanomedicine Inc
- Adamed Sp zoo
- ADC Therapeutics SA
- Adlai Nortye Biopharma Co Ltd
- Aduro BioTech Inc
- Advanced BioDesign
- Advanz Pharmaceutical Corp Ltd
- Advenchen Laboratories LLC
- Adze Biotechnology Inc
- Affimed GmbH
- Agenus Inc
- Agios Pharmaceuticals Inc
- AGV Discovery SAS
- AIkido Pharma Inc
- AIM ImmunoTech Inc
- Alissa Pharma
- Alkermes Plc
- Alligator Bioscience AB
- Allinky Biopharma SL
- Almac Discovery Ltd
- Alphamab Oncology
- AltruBio Inc
- ALX Oncology Inc
- amcure GmbH
- Amgen Inc
- AmMax Bio Inc
- Amphera BV
- Amplia Therapeutics Ltd
- Anavex Life Sciences Corp
- Andarix Pharmaceuticals Inc
- Andes Biotechnologies
- ANP Technologies Inc
- Antapodia Therapeutics Inc
- AntiCancer Inc
- Apac Biotech Pvt Ltd
- APEIRON Biologics AG
- Apexian Pharmaceuticals Inc
- Apexigen Inc
- Aphios Corp
- Apollomics Inc
- Aprilbio Co Ltd
- Aravive Inc
- Arbele Ltd
- Arcus Biosciences Inc
- Argonaut Therapeutics Ltd
- Asana BioSciences LLC
- Ascelia Pharma AB
- Ascenta Therapeutics Inc
- Ascentage Pharma Group International
- Ascentawits Pharmaceuticals Ltd
- Asclepiumm Taiwan Co Ltd
- Asclepius Technology Company Group Suzhou Co Ltd
- Astellas Pharma Inc
- AstraZeneca Plc
- Augustus BioTarget Inc
- AUM Biosciences Pte Ltd
- Aurigene Discovery Technologies Ltd
- Avenzoar Pharmaceuticals Inc
- AVEO Pharmaceuticals Inc
- Avican Inc
- Avicenna Therapeutics Inc
- Azure Health Technology Ltd
- Basilea Pharmaceutica Ltd
- Bausch Health Companies Inc
- Bavarian Nordic A/S
- Bayer AG
- BeiGene Ltd
- Beijing Syngentech Co Ltd
- Bellicum Pharmaceuticals Inc
- Benhealth Biopharmaceutical (Shenzhen) Co Ltd
- Berg LLC
- BerGenBio ASA
- Bessor Pharma LLC
- Betta Pharmaceuticals Co Ltd
- Bexion Pharmaceuticals LLC
- BeyondBio Inc
- BeyondSpring Inc
- Bicycle Therapeutics Plc
- Bio-Path Holdings Inc
- BioAtla LLC
- Biocon Ltd
- Biokine Therapeutics Ltd
- BioLineRx Ltd
- BioMed Valley Discoveries Inc
- BioMoti Ltd
- Biomunex Pharmaceuticals
- BioNTech SE
- BioTheryX Inc
- BioXcel Therapeutics Inc
- BJ Bioscience Inc
- BLR Bio LLC
- Boehringer Ingelheim International GmbH
- Bold Therapeutics Inc
- Bolt Biotherapeutics Inc
- BriaCell Therapeutics Corp
- BrightGene Bio-Medical Technology Co Ltd
- Bristol-Myers Squibb Co
- Calidi Biotherapeutics Inc
- Cancer Advances Inc
- Cancer Prevention Pharmaceuticals Inc
- Cancer Vaccines Ltd
- Candel Therapeutics
- Canget BioTekpharma LLC
- Cannabis Science Inc
- Cantargia AB
- Cantex Pharmaceuticals Inc
- Cardiff Oncology Inc
- CARsgen Therapeutics Ltd
- Cascade Prodrug Inc
- Cassiopea SpA
- CCRP Therapeutics GmbH
- Celldex Therapeutics Inc
- Celleron Therapeutics Ltd
- CellionBioMed Inc
- Cellivery Therapeutics Inc
- Cello Therapeutics Inc
- Celprogen Inc
- Celyad Oncology
- Cend Therapeutics Inc
- Centrose LLC
- CheMedImmune Inc
- ChemoCentryx Inc
- ChemRegen Inc
- Chengdu Jinrui Foundation Biotechnology Co Ltd
- Chimeric Therapeutics Ltd
- Chiome Bioscience Inc
- CHO Pharma Inc
- Cloaked Therapeutics LLC
- Clovis Oncology Inc
- CLS Therapeutics
- CNS Pharmaceuticals Inc
- COARE Biotechnology Inc
- COARE Holdings Inc
- Codiak BioSciences Inc
- Coherent Biopharma
- Convalife
- Convert Pharmaceuticals SA
- Corcept Therapeutics Inc
- Corvus Pharmaceuticals Inc
- Cotinga Pharmaceuticals Inc
- Counterpoint Biomedica LLC
- CPL Biologicals Pvt Ltd
- CrystalGenomics Inc
- CSPC Pharmaceutical Group Ltd
- CStone Pharmaceuticals Co Ltd
- Cumberland Pharmaceuticals Inc
- Curegenix Inc
- CureLab Oncology Inc
- CureMeta LLC
- Cyclacel Pharmaceuticals Inc
- Cyteir Therapeutics Inc
- CytImmune Sciences Inc
- Cytocom Inc
- Cytodyn Inc
- Cytonus Therapeutics Inc
- CytoTools AG
- Cytovia Inc
- CyTuVax BV
- DAE HWA Pharmaceutical Co Ltd
- Daiichi Sankyo Co Ltd
- Decoy Biosystems Inc
- DEKK-TEC Inc
- Delta-Fly Pharma Inc
- DeMelle OncoPharma LLC
- DevaCell Inc
- Diakonos Research Ltd
- Diazon Pharmaceuticals Inc
- Diffusion Pharmaceuticals Inc
- Diverse Biotech Inc
- Domain Therapeutics SA
- DwarfBody-Therapeutics Operating Co BV
- eFFECTOR Therapeutics Inc
- Eisai Co Ltd
- Eleison Pharmaceuticals LLC
- Eli Lilly and Co
- Elicio Therapeutics
- Elthera AG
- ENB Therapeutics LLC
- EnGeneIC Ltd
- Engitix Ltd
- Enochian Biosciences Inc
- Epeius Biotechnologies Corp
- Epidestiny Inc
- Epigene Therapeutics Inc
- Ergon Pharmaceuticals LLC
- ERYTECH Pharma SA
- Esanex Inc
- Escend Pharmaceuticals Inc
- Esperance Pharmaceuticals Inc
- Esperas Pharma Inc
- Essential Biotechnology LLC
- Eucure (Beijing) Biopharma Co Ltd
- Eureka Therapeutics Inc
- Eutilex Co Ltd
- Everfront Biotech Inc
- Evestra Inc
- Exelixis Inc
- EXUMA Biotech Inc
- F. Hoffmann-La Roche Ltd
- Faron Pharmaceuticals Oy
- Fate Therapeutics Inc
- Felicitex Therapeutics Inc
- FibroGen Inc
- Flag Therapeutics Inc
- Flavocure Biotech LLC
- Formosa Pharmaceuticals Inc
- Fujifilm Holdings Corp
- Galera Therapeutics Inc
- GamaMabs Pharma SA
- Gbiologics Inc
- GC Pharma
- GEEN Biotechnology Inc
- Geistlich Pharma AG
- GEMoaB Monoclonals GmbH
- GeneCare Research Institute Co Ltd
- Geneius Biotechnology Inc
- Genelux Corp
- Genemedicine Ltd
- Genentech USA Inc
- Geneos Therapeutics Inc
- GeneScience Pharmaceuticals Co Ltd
- Genexine Inc
- Genisphere LLC
- Genmab AS
- Genomefrontier Therapeutics Inc
- Genoscience Pharma
- GeoVax Labs Inc
- Gilead Sciences Inc
- GlaxoSmithKline Plc
- GlycoMimetics Inc
- GlycoNex Inc
- GO Therapeutics Inc
- Golden Biotechnology Corp
- Gossamer Bio Inc
- Gracell Biotechnology Ltd
- Gradalis Inc
- Gritstone Oncology Inc
- Guangdong Zhongsheng Pharmaceutical Co Ltd
- Guangzhou Sinogen Pharmaceutical Co Ltd
- H2Biologics Inc
- HaimBio Ltd
- Hangzhou DAC Biotech Co Ltd
- Hangzhou Neoantigen Therapeutics Co Ltd
- Hanmi Pharmaceuticals Co Ltd
- Harbin Gloria Pharmaceuticals Co Ltd
- Harpoon Therapeutics Inc
- Hebei Senlang Biotechnology Inc Ltd
- HEC Pharm Co Ltd
- Heidelberg Pharma AG
- Helix BioPharma Corp
- Helixmith Co Ltd
- Hibercell Inc
- Hope Biosciences Inc
- Hope Biosciences LLC
- Huabo Biopharm Co Ltd
- Hummingbird Bioscience Pte Ltd
- Hyundai Bioscience Co., Ltd.
- i2 Pharmaceuticals Inc
- iCELL Biotechnology Co Ltd
- Icell Kealex Therapeutics LLC
- Ideaya Biosciences Inc
- Idera Pharmaceuticals Inc
- ImCheck Therapeutics SAS
- Immix BioPharma Inc
- Immodulon Therapeutics Ltd
- Immune System Key Ltd
- Immunitor Inc
- ImmunityBio Inc
- Immunogenesis Inc
- Immunomedics Inc
- ImmunoRestoration Inc
- Immunos Therapeutics AG
- Immunotope Inc
- Immunovo BV
- ImmunSYS Inc
- Immupharma Plc
- Imugene Ltd
- Incanthera Ltd
- Incyte Corp
- Inflection Biosciences Ltd
- Innate Pharma SA
- InnoMab Pte Ltd
- Innopharmax Inc
- Innovation Pharmaceuticals Inc
- Innovative Cellular Therapeutics Co Ltd
- Inovio Pharmaceuticals Inc
- Intensity Therapeutics Inc
- InteRNA Technologies BV
- Intrepida Bio Inc
- Inventiva
- InvivoGen Therapeutics
- InxMed Shanghai Co Ltd
- IO Biosciences Inc
- Io Therapeutics Inc
- Ionic Pharmaceuticals LLC
- Ionova Life Science Co Ltd
- Iovance Biotherapeutics Inc
- Ipsen SA
- ISU ABXIS Co Ltd
- January Therapeutics Inc
- JenKem Technology Co Ltd
- Jiangsu Hengrui Medicine Co Ltd
- Jivana Biotechnology Inc
- Johnson & Johnson
- Kalos Therapeutics Inc
- Kalyra Pharmaceuticals Inc
- Kangen Pharmaceuticals Co Ltd
- Kanyr Pharma Inc
- Karyopharm Therapeutics Inc
- Kazia Therapeutics Ltd
- Keystone Nano Inc
- Kitov Pharma Ltd
- KLUS Pharma Inc
- Komipharm International Co Ltd
- Kringle Pharma Inc
- Kupffer Biotherapeutics Inc
- Kymab Ltd
- Kyowa Kirin Co Ltd
- L.E.A.F. Pharmaceuticals LLC
- LA Cell Inc
- Lantern Pharma Inc
- Le Sun Pharmaceuticals Ltd
- Lead Discovery Center GmbH
- Legend Biotech Corp
- Leucid Bio Ltd
- LIfT BioSciences Ltd
- Liminal BioSciences Inc
- Linnaeus Therapeutics Inc
- Lipomedics Ltd
- LipoSeuticals Inc
- Lixte Biotechnology Holdings Inc
- Lodo Therapeutics Corp
- Loki Therapeutics Inc
- Lokon Pharma AB
- Loxo Oncology Inc
- Luminus Biosciences Inc
- Lumobiotics GmbH
- Lumosa Therapeutics Co Ltd
- Luye Pharma Group Ltd
- Lykera biomed SA
- MabVax Therapeutics Holdings Inc
- Machavert Pharmaceuticals LLC
- MacroGenics Inc
- Marino Biotechnology Co Ltd
- Marker Therapeutics Inc
- Max Biopharma Inc
- MaxiVAX SA
- Meabco AS
- MediaPharma SRL
- Medical Guidance Systems LLC
- Medicenna Therapeutics Corp
- MediciNova Inc
- Medicon Pharmaceuticals Inc
- MedPacto Inc
- Mekanistic Therapeutics LLC
- Merck & Co Inc
- Merck KGaA
- Mereo Biopharma Group Plc
- Merus NV
- MetiMedi Pharmaceuticals Co Ltd
- Metis Precision Medicine
- Metromedia Bio-Science LLC
- Migra-Therapeutics LLC
- Millennium Pharmaceuticals Inc
- Mina Therapeutics Ltd
- Minneamrita Therapeutics LLC
- Mirati Therapeutics Inc
- Moderna Inc
- Modulus Oncology Ltd
- Molecular Partners AG
- Molecular Targeting Technologies Inc
- Molecular Templates Inc
- Moleculin Biotech Inc
- Momotaro-Gene Inc
- Monopar Therapeutics Inc
- Mundipharma EDO GmbH
- Mustang Bio Inc
- Mycenax Biotech Inc
- Nanjing Bioheng Biotech Co Ltd
- Nanjing Iaso Biotherapeutics Co Ltd
- NanoCarrier Co Ltd
- Nanogenics Ltd
- Nanology LLC
- NanoPharmaceuticals LLC
- NantBioScience Inc
- NantKwest Inc
- Nascent Biotech Inc
- Navire Pharma Inc
- Nektar Therapeutics
- NeoTX Therapeutics Ltd
- New B Innovation Ltd
- NGM Biopharmaceuticals Inc
- Nitto BioPharma Inc
- NMS Group SpA
- NomoCan Pharmaceuticals LLC
- Northern Biologics Inc
- Northwest Biotherapeutics Inc
- NovalGen Ltd
- NovaRock Biotherapeutics Inc
- Novartis AG
- Novita Pharmaceuticals Inc
- Novonco Pharmaceuticals Inc
- NOX Pharmaceuticals Inc
- Noxxon Pharma AG
- OBI Pharma Inc
- Oceanyx Pharmaceuticals Inc
- Omeros Corp
- OncBioMune Pharmaceuticals Inc
- Oncoceutics Inc
- Oncocross Co Ltd
- Oncodesign SA
- Oncology Research International Ltd
- Oncology Venture A/S
- Oncolys BioPharma Inc
- Oncolytics Biotech Inc
- Oncomatryx Biopharma SL
- OncoOne Research & Development GmbH
- OncoQuest Inc
- OncoSec Medical Inc
- OncoTAb Inc
- Oncotelic Inc
- OncoTherapy Science Inc
- OncoTherics Ltd
- OncoTrap Inc
- Oncovir Inc
- OncXerna Therapeutics Inc
- Oneness Biotech Co Ltd
- Ono Pharmaceutical Co Ltd
- Opsona Therapeutics Ltd
- Optimum Therapeutics LLC
- Orano Med LLC
- Oregon Therapeutics
- Orgenesis Inc
- Oribase Pharma
- ORIC Pharmaceuticals Inc
- Oryx GmbH & Co KG
- OSE Immunotherapeutics
- Oxford BioTherapeutics Ltd
- Palisades Therapeutics
- PanTher Therapeutics Inc
- Patrys Ltd
- Peptron Inc
- PersonGen Biomedicine Suzhou Co Ltd
- Pfizer Inc
- Phanes Therapeutics Inc
- Pharma Mar SA
- PharmAbcine Inc
- PharmaCyte Biotech Inc
- Pharmaxis Ltd
- Phenex Pharmaceuticals AG
- pHion Therapeutics Ltd
- Phoenix Biotechnology Inc
- Phoenix Life Sciences International Ltd
- Phosplatin Therapeutics LLC
- Pieris Pharmaceuticals Inc
- Placon Therapeutics Inc
- Plexxikon Inc
- Plus Therapeutics Inc
- PNB Vesper Life Science Pvt Ltd
- POP Biotechnologies Inc
- Poseida Therapeutics Inc
- Precision Biologics Inc
- Prescient Therapeutics Ltd
- Prestige BioPharma Pte Ltd
- PRISM Pharma Co Ltd
- Processa Pharmaceuticals Inc
- ProDa BioTech LLC
- Propanc Biopharma Inc
- Protheragen Inc
- Provectus Biopharmaceuticals Inc
- Psivac Ltd
- Puma Biotechnology Inc
- Purdue Pharma LP
- Puretech Health Plc
- Qu Biologics Inc
- Quadriga BioSciences Inc
- Qualigen Therapeutics Inc
- Quest PharmaTech Inc
- Quimatryx SL
- Qurgen Inc
- RadImmune Therapeutics Inc
- Rafael Pharmaceuticals Inc
- Redbiotec AG
- RedHill Biopharma Ltd
- Redx Pharma Plc
- Regeneron Pharmaceuticals Inc
- RemeGen Ltd
- Resarci Therapeutics LLC
- Resonant Therapeutics Inc
- Reven Pharmaceuticals Inc
- Revolution Medicines Inc
- Rexahn Pharmaceuticals Inc
- Rgenix Inc
- Rhizen Pharmaceuticals SA
- Rigenerand Srl
- Rimo Therapeutics Inc
- Riptide Bioscience Inc
- Rise Biopharmaceutical Ltd
- RS Research
- Sagetis Biotech SL
- Sagimet Biosciences
- Samumed LLC
- Samyang Holdings Corp
- Sanofi
- Sapphire Biotech Inc
- Sareum Holdings Plc
- SATT Nord
- Savoy Pharmaceuticals Inc
- Scancell Holdings Plc
- Scandion Oncology AS
- ScarTec Therapeutics BV
- Schrodinger LLC
- Seattle Genetics Inc
- SEEKYO Therapeutics
- Segue Therapeutics LLC
- SELLAS Life Sciences Group Inc
- Senhwa Biosciences Inc
- Senti Biosciences Inc
- SevenGenes Inc
- Shanghai Biomed-Union Biotechnology Co Ltd
- Shanghai Bioray Laboratory Inc
- Shanghai Fosun Pharmaceutical (Group) Co Ltd
- Shanghai GeneChem Co Ltd
- Shanghai Haihe Biopharma Co Ltd
- Shanghai Huilun Life Science&Technology Co Ltd
- Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
- Shenzhen BinDeBio Ltd
- Shenzhen Hepalink Pharmaceutical Group Co Ltd
- Shijiazhuang Yiling Pharmaceutical Co Ltd
- Siamab Therapeutics Inc
- Sichuan Kelun Pharmaceutical Co Ltd
- Signablok Inc
- SignalChem Lifesciences Corp
- SignalRx Pharmaceuticals Inc
- SilaGene Inc
- Silenseed Ltd
- Sillajen Biotherapeutics
- Singh Biotechnology LLC
- Sino Biopharmaceutical Ltd
- Sinocelltech Ltd
- siRNAgen Therapeutics Corp
- Sirnaomics Inc
- SN BioScience
- Soluventis GmbH
- Sonoval LLC
- Soricimed Biopharma Inc
- Sorrento Therapeutics Inc
- Speratum
- Spring Bank Pharmaceuticals Inc
- SpringWorks Therapeutics Inc
- Starpharma Holdings Ltd
- Stcube Inc
- Stemirna Therapeutics Inc
- Sublime Therapeutics
- Sumitomo Dainippon Pharma Oncology, Inc
- Sun BioPharma Inc
- Suzhou Sinovent Pharmaceuticals Co Ltd
- SynCore Biotechnology Co Ltd
- Syndivia SAS
- SynerGene Therapeutics Inc
- Synovo GmbH
- SyntheX Inc
- Syntrix Biosystems Inc
- T-Cure Bioscience Inc
- TAE Life Sciences LLC
- Taiho Oncology Inc
- Taiho Pharmaceutical Co Ltd
- Takara Bio Inc
- Takeda Pharmaceutical Co Ltd
- Takis Srl
- TargaGenix Inc
- Targovax ASA
- Tarveda Therapeutics Inc
- Telesis Therapeutics LLC
- Telix Pharmaceuticals Ltd
- tella Inc
- Tempest Therapeutics Inc
- TenCure Ltd
- Tessa Therapeutics Ltd
- TEZCAT Laboratories
- TGV Laboratories Inc
- The National Institute for Biotechnology in the Negev Ltd
- TherapyX Inc
- Tianjin Hengjia Biotechnology Development Co Ltd
- Tiziana Life Sciences Plc
- Tmunity Therapeutics Inc
- Tonix Pharmaceuticals Holding Corp
- TOT Biopharm Co Ltd
- Transcenta Holding Ltd
- Transcode Therapeutics Inc
- Transcriptogen Ltd
- Transgene SA
- Transtarget Inc
- Treadwell Therapeutics Inc
- Trio Medicines Ltd
- TriSalus Life Sciences Inc
- Trishula Therapeutics Inc
- TVAX Biomedical Inc
- Twoxar Inc
- Tyg Oncology Ltd
- Tyme Technologies Inc
- UbiVac LLC
- Vaccinex Inc
- ValiRx Plc
- Valiseek Ltd
- Vanquish Oncology Inc
- VasGene Therapeutics Inc
- Vault Pharma Inc
- Vaximm AG
- VCN Biosciences SL
- Vect-Horus SAS
- Venus Remedies Ltd
- Verastem Inc
- Vertex Pharmaceuticals Inc
- Veru Inc
- Vicus Therapeutics LLC
- Vigeo Therapeutics Inc
- Viral Gene Inc
- Viralytics Pty Ltd
- Virobay Inc
- ViroStatics SRL
- Vivacitas Oncology Inc
- VM Discovery Inc
- Voronoi Group
- Westwood Bioscience Inc
- Wntrix Inc
- Worphmed Srl
- WuXi AppTec Co Ltd
- Xencor Inc
- XTuit Pharmaceuticals Inc
- XuanZhu Pharma Co Ltd
- Y-Biologics Inc
- Yisheng Biopharma Co Ltd
- Zelira Therapeutics Ltd
- Zelluna Immunotherapy AS
- Zhejiang Teruisi Pharmaceutical Inc
- Zhejiang Yangshengtang Biotech Co Ltd
- Zhengda Tianqing Kangfang Shanghai Biomedical Technology Co Ltd
- Zonula Inc
- Zovis Pharmaceuticals
- Zucero Therapeutics Ltd
